Introducing
Crexont
Carbidopa and levodopa
For adults with Parkinson’s disease
People walking a dog
Gradient background
Gradient background

12,147+ patients in the United States have been prescribed CREXONT1

David,
a real person with Parkinson’s disease

For adults with Parkinson’s disease (PD)

From lunch to leash to lake

Stay in step with your day with CREXONT: More “Good On” time* with less frequent dosing compared with 
immediate-release carbidopa/levodopa (IR CD/LD)†

*“Good On” time is defined as “On” time without troublesome dyskinesia.

†As seen in a clinical study.

arrow down

Take your next step

More “Good On” time* with less
frequent dosing compared to IR CD/LD

Tablet icon

Designed to gradually release levodopa

CREXONT is designed to gradually release levodopa in the part of the gut where it is best absorbed, although the exact site and duration of absorption is unknown
arrow up


More “Good On” time*

People who took CREXONT an average of 3 times a day achieved 30 minutes more “Good On” time per day than those taking IR CD/LD an average of 5 times a day

pill icon


Personalized dosing

CREXONT dosing starts at 3 times per day for most patients, though dosing may start at 2 to 3 times per day. After 1 to 3 days, your doctor may adjust your dose or frequency. CREXONT may be dosed up to 4 times a day

Play Video

CREXONT has transformed innovation into duration 

For the first time in Parkinson’s disease, an oral therapy was designed to target where levodopa is best absorbed—the proximal small intestine—making CREXONT the oral CD/LD formulation with the longest-lasting LD plasma levels.†‡
Exact site and duration of absorption are unknown. In a clinical pharmacology study, the duration of levodopa levels was defined by how long the levels of CREXONT, RYTARY, and IR CD/LD were maintained in the blood above half the maximum concentration.

Are you optimizing your “Good On” time* with your current Parkinson’s disease treatment?

IR CD/LD has been the standard of care for treating PD for many years—it’s designed to work quickly but may wear off quickly too.

Birthday Image

See real stories from real people

Learn how CREXONT helps people who are living with Parkinson’s disease.
“I’ve always been positive and upbeat—it killed me to say I didn’t feel good,” Lori says. “Now I can genuinely say I feel [like myself again].”
-Lori
“I found something that helps me feel more like my old self again,” he says. “That matters. I just want to live my life.”
-Jeffrey
“We’re all on this journey together. And if I can help someone feel even a little less afraid of the future, then I’ve done what I set out to do.”
-Navin

Footnotes

*“Good On” time is defined as “On” time without troublesome dyskinesia.

†As seen in a clinical study.

‡Change in “Good On” time was measured by comparing values at the end of study to baseline; P=0.019 vs IR CD/LD.

1. Data on file. Amneal Pharmaceuticals LLC.

You are now leaving this site

This link will take you to a different site that is owned and operated by an independent third party to which the Privacy Policy does not apply.
Are you sure you want to continue?